These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8877713)

  • 21. T lymphocytes determine the development of xeno GVHD and of human hemopoiesis in NOD/SCID mice following human umbilical cord blood transplantation.
    Verlinden SF; Mulder AH; de Leeuw JP; van Bekkum DW
    Stem Cells; 1998; 16 Suppl 1():205-17. PubMed ID: 11012164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem cell factor improves SCID-repopulating activity of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model.
    Zheng Y; Sun A; Han ZC
    Bone Marrow Transplant; 2005 Jan; 35(2):137-42. PubMed ID: 15543197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The plant mannose-binding lectin NTL preserves cord blood haematopoietic stem/progenitor cells in long-term culture and enhances their ex vivo expansion.
    Li K; Ooi VE; Chuen CK; Lam AC; Ooi LS; Zhang XB; Tsang KS; Chiu LC; Chan KY; Li CK; Fok TF; Yuen PM; Ng PC
    Br J Haematol; 2008 Jan; 140(1):90-8. PubMed ID: 17908183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel immunodeficient mouse model--RAG2 x common cytokine receptor gamma chain double mutants--requiring exogenous cytokine administration for human hematopoietic stem cell engraftment.
    Mazurier F; Fontanellas A; Salesse S; Taine L; Landriau S; Moreau-Gaudry F; Reiffers J; Peault B; Di Santo JP; de Verneuil H
    J Interferon Cytokine Res; 1999 May; 19(5):533-41. PubMed ID: 10386866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.
    Nauta AJ; Kruisselbrink AB; Lurvink E; Mulder A; Claas FH; Noort WA; Willemze R; Fibbe WE
    Exp Hematol; 2005 Oct; 33(10):1249-56. PubMed ID: 16219548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of serum-free culture conditions able to support the ex vivo expansion and engraftment of human hematopoietic stem cells in the human-to-sheep xenograft model.
    Almeida-Porada G; Brown RL; MacKintosh FR; Zanjani ED
    J Hematother Stem Cell Res; 2000 Oct; 9(5):683-93. PubMed ID: 11091492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility of cord blood stem cell manipulation with high-energy shock waves: an in vitro and in vivo study.
    Berger M; Frairia R; Piacibello W; Sanavio F; Palmero A; Venturi C; Pignochino Y; Berta L; Madon E; Aglietta M; Fagioli F
    Exp Hematol; 2005 Nov; 33(11):1371-87. PubMed ID: 16263422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in the cytokine regulation of stem cell self-renewal during ontogeny.
    Eaves C; Zandstra P; Conneally E; Miller C; Cashman J; Petzer A; Piret J
    Stem Cells; 1998; 16 Suppl 1():177-84. PubMed ID: 11012160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced in vivo motility of human umbilical cord blood hematopoietic stem/progenitor cells introduced via intra-bone marrow injection into xenotransplanted NOD/SCID mouse.
    Gao J; Li Y; Lu S; Wang M; Yang Z; Yan X; Zheng Y
    Exp Hematol; 2009 Aug; 37(8):990-7. PubMed ID: 19481136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coculture and transplant of purified CD34(+)Lin(-) and CD34(-)Lin(-) cells reveals functional interaction between repopulating hematopoietic stem cells.
    Hess DA; Karanu FN; Levac K; Gallacher L; Bhatia M
    Leukemia; 2003 Aug; 17(8):1613-25. PubMed ID: 12886251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of purified and ex vivo manipulated human hematopoietic progenitor and stem cells in xenograft recipients.
    Bock TA; Ziegler BL; Bühring HJ; Scheding S; Brugger W; Kanz L
    Ann N Y Acad Sci; 1999 Apr; 872():200-7; discussion 207-10. PubMed ID: 10372123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engraftment of human CD34+ cells leads to widespread distribution of donor-derived cells and correction of tissue pathology in a novel murine xenotransplantation model of lysosomal storage disease.
    Hofling AA; Vogler C; Creer MH; Sands MS
    Blood; 2003 Mar; 101(5):2054-63. PubMed ID: 12406886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zebrafish In-Vivo Screening for Compounds Amplifying Hematopoietic Stem and Progenitor Cells: - Preclinical Validation in Human CD34+ Stem and Progenitor Cells.
    Arulmozhivarman G; Kräter M; Wobus M; Friedrichs J; Bejestani EP; Müller K; Lambert K; Alexopoulou D; Dahl A; Stöter M; Bickle M; Shayegi N; Hampe J; Stölzel F; Brand M; von Bonin M; Bornhäuser M
    Sci Rep; 2017 Sep; 7(1):12084. PubMed ID: 28935977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo.
    Zhang S; Wang D; Estrov Z; Raj S; Willerson JT; Yeh ET
    Circulation; 2004 Dec; 110(25):3803-7. PubMed ID: 15596566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma.
    Groen RW; Noort WA; Raymakers RA; Prins HJ; Aalders L; Hofhuis FM; Moerer P; van Velzen JF; Bloem AC; van Kessel B; Rozemuller H; van Binsbergen E; Buijs A; Yuan H; de Bruijn JD; de Weers M; Parren PW; Schuringa JJ; Lokhorst HM; Mutis T; Martens AC
    Blood; 2012 Jul; 120(3):e9-e16. PubMed ID: 22653974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunodeficient mice as models of human hematopoietic stem cell engraftment.
    Dao MA; Nolta JA
    Curr Opin Immunol; 1999 Oct; 11(5):532-7. PubMed ID: 10508705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of parameters that affect human hematopoietic cell outputs in mutant c-kit-immunodeficient mice.
    Miller PH; Rabu G; MacAldaz M; Knapp DJ; Cheung AM; Dhillon K; Nakamichi N; Beer PA; Shultz LD; Humphries RK; Eaves CJ
    Exp Hematol; 2017 Apr; 48():41-49. PubMed ID: 28087429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A method for transplantation of human HSCs into zebrafish, to replace humanised murine transplantation models.
    Hamilton N; Sabroe I; Renshaw SA
    F1000Res; 2018; 7():594. PubMed ID: 29946444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.